NOBLEOAK LIFE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.545 AUD | -2.98% |
|
-0.32% | -6.93% |
| Feb. 28 | NobleOak Life Shares Add 7% Despite 55% Plunge in Fiscal H1 Profit | MT |
| Feb. 28 | Transcript : NobleOak Life Limited, H1 2024 Earnings Call, Feb 28, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- With a P/E ratio at 10.79 for the current year and 8.99 for next year, earnings multiples are highly attractive compared with competitors.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company sustains low margins.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Life & Health Insurance
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -6.93% | 91.96M | - | ||
| +25.10% | 107B | B- | ||
| -4.26% | 93.7B | B+ | ||
| +17.05% | 73.99B | D+ | ||
| +21.74% | 35.28B | B | ||
| +15.12% | 30.15B | A | ||
| +16.59% | 29.95B | B | ||
| +0.51% | 17.31B | C+ | ||
| -11.95% | 14.7B | B | ||
| +27.55% | 13.54B | A- |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- NOL Stock
- Ratings NobleOak Life Limited
